Nefopam is more potent than carbamazepine for neuroprotection against veratridine in vitro and has anticonvulsant properties against both electrical and chemical stimulation

Amino Acids

Volumn 32, Issue 3, 2007, Pages 323-332

  Novelli, A ^a   Groppetti, A ^b   Rossoni, G ^b   Manfredi, B ^b   Ferrero Gutierrez A ^a   Perez Gomez A ^a   Desogus, C M ^a   Fernandez Sanchez M T ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Behaviour; Carbamazepine; Cultured cerebellar neurons; Nefopam; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL L TYPE; CARBAMAZEPINE; DIAZEPAM; GLUTAMIC ACID; ISONIAZID; NEFOPAM; NEUROPROTECTIVE AGENT; VERATRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CEREBELLUM; CLONUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ELECTRIC SHOCK; ELECTROSTIMULATION; EXCITOTOXICITY; MALE; MOUSE; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; STIMULATION; TREATMENT FAILURE;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANTICONVULSANTS; ANTITUBERCULAR AGENTS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CARBAMAZEPINE; CELLS, CULTURED; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; GLUTAMIC ACID; ISONIAZID; MALE; MICE; NEFOPAM; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; VERATRIDINE;

MUS; RODENTIA;

EID: 34147165503     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-006-0419-6     Document Type: Article

References (52)

1. S Ahmad LJ Fowler PS Whitton 2005 Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids Epilepsy Res 63 141 149
2. P Alfonsi F Adam A Passard B Guignard DI Sessler M Chauvin 2004 Nefopam, a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unanesthetized subjects Anesthesiology 100 37 43
3. 2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists Neuropharmacology 38 1349 1359
4. JP Belleville F Dorey JW Bellville 1979 Effects of nefopam on visual tracking Clin Pharmacol Ther 26 457 463
5. R Bernasconi P Martin AF Steulet C Portet T Leonhardt M Schmutz 1992 Effects of benzodiazepine receptor ligands with different intrinsic activities on seizures induced by inhibition of GAD Epilepsy Res Suppl 8 87 96
6. GE Biella A Groppetti A Novelli MT Fernández-Sánchez B Manfredi ML Sptgiu 2003 Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine J Neurotrauma 20 593 601
7. + channels: local anesthetics, antiarrythmics and anticonvulsants Trends Pharmacol Sci 8 57 65
8. G De Sarro C Ascioti ED di Paola MJ Vidal A De Sarro 1992 Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage dependent L calcium channel in DBA/2 mice Gen Pharmacol 23 1205 1216
9. NW Dunham TS Miya 1957 A note on a simple apparatus for detecting neurological deficit in rats and mice J Am Pharmaceut Assoc 46 208 209
10. E Esposito S Romandini E Merlo-Pich T Mennini R Samanin 1986 Evidence of the involvement of dopamine in the analgesic effect of nefopam Eur J Pharmacol 128 157 164
11. OB Fasmer OG Berge HA Jørgensen K Hole 1987 Antinoceptive effects of (±)-, (+)- and (-) nefopam in mice J Pharm Pharmacol 39 508 511
12. MT Fernández V Zitko S Gascón A Novelli 1991 The marine toxin okadaic acid is a potent neurotoxin for cultured cerebellar neurons Life Sci 49 PL157 PL162
13. MT Fernández-Sánchez R Díaz-Trelles A Groppetti B Manfredi AT Brini G Biella ML Sotgiu A Novelli 2001 Novel effect of nefopam preventing cGMP increase, oxygen radical formation and neuronal death induced by veratridine Neuropharmacology 41 935 942
14. MT Fernández-Sánchez R Díaz-Trelles A Groppetti B Manfredi AT Brini G Biella ML Sotgiu A Novelli 2002 Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent veratridine-induced neurotoxicity Amino Acids 23 31 36
15. NB Finnerup H Gottrup TS Jensen 2002 Anticonvulsants in central pain Expert Opin Pharmacother 3 1411 1420
16. RW Fuller HD Snoddy 1993 Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice Neuropharmacology 32 995 999
17. JC Gasser JW Bellville 1975 Respiratory effects of nefopam Clin Pharmacol Ther 18 175 179
18. HU Gerbershagen E Schaffner 1979 Respiratory effect of nefopam Clin Ther 2 Suppl B 17 39 42
19. F Guirimand X Dupont D Bouhassira L Brasseur M Chauvin 1999 Nefopam strongly depresses the nociceptive flexion (R(III)) reflex in humans Pain 80 399 404
20. RC Heel RN Brogden GE Pakes TM Speight GS Avery 1980 Nefopam: a review of its pharmacological properties and therapeutic efficacy Drugs 19 249 267
21. S Hunskaar OB Fasmer OJ Broch K Hole 1987 Involvement of central serotonergic pathways in nefopam-induced antinoception Eur J Pharmacol 138 77 82
22. J Ichikawa HY Meltzer 1999 Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation Eur J Pharmacol 380 R1 R3
23. J Ichikawa J Dai HY Meltzer 2005 Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism Brain Res 1049 182 190
24. DR Jasinski KL Preston 1987 A comparative assay of nefopam, morphine and d-amphetamine Psychopharmacology 91 273 278
25. JPY Kao AT Harootunian RY Tsien 1989 Photochemically generated cytosolic calcium pulses and their detection by Fluo-3 J Biol Chem 264 8179 8184
26. M Kito M Maehara K Watanabe 1994 Antiepileptic drugs - calcium current interaction in cultured human neuroblastoma cells Seizure 3 141 149
27. S Kochen B Giagante S Oddo 2002 Spike-and-wave complexes and seizure exacerbation caused by carbamazepine Eur J Neurol 9 41 47
28. BK Koe 1976 Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain J Pharmacol Exp Ther 199 649 661
29. J Kornhuber CG Parsons S Hartmann W Retz S Kamolz J Thome P Riederer 1995 Orphenadrine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: binding and patch clamp studies J Neural Transm 102 237 246
30. GG Mather R Labroo ME Le Guern F Lepage JM Gillardin RH Levy 2000 Nefopam enantiomers: preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administration Chirality 12 153 159
31. S Mignani GA Bohme G Birraux A Boireau P Jimonet D Damour A Genevois-Borella MW Debono J Pratt M Vuilhorgne F Wahl JM Stutzmann 2002 9-Carboxymethyl-5H,10H-imidazo[1,2-a] indeno[1,2-e]pyrazin-4one-2-carbocylic acid (RPR117824): selective anticonvulsive and neuroprotective AMPA antagonist Bioorg Med Chem 10 1627 1637
32. T Murakami M Okada Y Kawata G Zhu A Kamata S Kaneko 2001 Determination of effects of antiepileptic drugs on SNAREsmediated hippocampal monoamine release using in vivo microdialysis Br J Pharmacol 134 507 520
33. A Novelli JA Reilly PG Lypsko RC Henneberry 1988 Glutamate becomes neurotoxic via the NMDA receptor when intracellular energy levels are reduced Brain Res 451 205 212
34. A Novelli R Díaz-Trelles A Groppetti MT Fernández- Sánchez 2006 Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels Amino Acids 30 183 191
35. PI Pillans DJ Woods 1995 Adverse reactions associated with nefopam NZ Med J 108 382 384
36. SN Piper SW Suttner CC Schmidt WH Maleck B Kumle J Boldt 1999 Nefopam and clonidine in the prevention of postanaesthetic shivering Anaesthesia 54 695 699
37. G Rosa G Pinto P Orsi RA de Blasi G Conti R Sanita I La Rosa A Gasparetto 1995 Control of post anaesthetic shivering with nefopam hydrochloride in mildly hypothermic patients after neurosurgery Acta Anaesthesiol Scand 39 90 95
38. JH Rosland K Hole 1990 The effect of nefopam and its enantiomers on the uptake of 5-hydroxytryptamine, noradrenaline and dopamine in crude rat brain synaptosomal preparations J Pharm Pharmacol 42 437 438
39. K Schirrmacher A Mayer J Walden R Dusing D Bingmann 1993 Effects of carbamazepine on action potentials and calcium currents in rat spinal ganglion cells in vitro Neuropsychobiology 27 176 179
40. TB Schumacher H Beck C Steinhauser J Schramm CE Elger 1998 Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy Epilepsia 39 355 363
41. i in cultured rat hippocampal neurons following exposure to N-methyl-D-aspartate J Physiol 448 655 676
42. M Serra MC Foddi CA Ghiani MA Melis C Motzo A Concas E Sanna G Biggio 1992 Pharmacology of gamma-aminobutyric acid. A receptor complex after the in vivo administration of the anxioselective and anticonvulsant beta-carboline derivative abecarnil J Pharmacol Exp Ther 263 1360 1368
43. A Stefani F Spadoni G Bernardi 1997 Voltage-activated calcium channels: targets of antiepileptic drug therapy? Epilepsia 38 959 965
44. EA Swinyard WC Brown LS Goodman 1952 Comparative assays of epileptic drugs in mice and rats J Pharmacol Exp Ther 106 319 330
45. EA Swinyard AN Castellion GB Fink LS Goodman 1963 Some neurophysiological and neuropharmacological characteristics of audiogenic seizure susceptible mice J Pharmacol Exp Ther 140 375 384
46. WE Tobin RH Gold 1972 Nefopam hydrochloride: a novel muscle relaxant J Clin Pharmacol New Drugs 12 230 238
47. SC Urwin RS Smith 1999 Fatal nefopam overdose Br J Anaesthesiol 83 501 502
48. M Verleye N André I Heulard J-M Gillardin 2004 Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents Brain Res 1013 249 255
49. C Villier MP Mallaret 2002 Nefopam abuse Ann Pharmacother 36 1564 1566
50. PF Vonvoigtlander RA Lewis GL Neff Triezenberg 1983 Involvement of biogenic amines with the mechanisms of novel analgesics Prog Neuropsychopharmacol Biol Psychiatry 7 651 656
51. M Willow WA Catterall 1982 Inhibition of binding of [3H] batrachotoxinin A 20-a-benzoate to sodium channels by the anticonvulsant drugs dyphenylhydantoin and carbamazepine Mol Pharmacol 22 627 635
52. 2+ channel on acetylcholine release in rat frontal cortex Epilepsy Res 49 49 60